{"title":"Preparation of bi-layer composite films for controlled cefazolin delivery and enhanced antibacterial activity","authors":"Gizem Şanlıtürk, Mümtaz Güran, Mustafa Gazi","doi":"10.1080/00914037.2024.2367205","DOIUrl":null,"url":null,"abstract":"In the present study, a wide-spectrum antibiotic drug, cefazolin was loaded into novel bi-layer composite films based on chitosan and alginate. The objective was to achieve sustained antibacterial ...","PeriodicalId":14203,"journal":{"name":"International Journal of Polymeric Materials and Polymeric Biomaterials","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Polymeric Materials and Polymeric Biomaterials","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1080/00914037.2024.2367205","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
In the present study, a wide-spectrum antibiotic drug, cefazolin was loaded into novel bi-layer composite films based on chitosan and alginate. The objective was to achieve sustained antibacterial ...
期刊介绍：
International Journal of Polymeric Materials and Polymeric Biomaterials is the official publication of the International Society for Biomedical Polymers and Polymeric Biomaterials (ISBPPB). This journal provides a forum for the publication of peer-reviewed, English language articles and select reviews on all aspects of polymeric materials and biomedical polymers. Being interdisciplinary in nature, this journal publishes extensive contributions in the areas of encapsulation and controlled release technologies to address innovation needs as well.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
